Moshe Arkin

Moshe Arkin has an estimated net worth of $283 Million. This is based on reported shares across multiple companies, which include Orexigen Therapeutics, Inc., Keros Therapeutics, Inc., NeurogesX Inc, PERRIGO CO, Werewolf Therapeutics, Inc., OPHTHALMIC IMAGING SYSTEMS, Odysight.ai Inc., and Sol-Gel Technologies Ltd..

2010 was Moshe Arkin's most active year for acquiring shares with 28 total transactions. Moshe Arkin's most active month to acquire stocks was the month of July. 2008 was Moshe Arkin's most active year for disposing of shares, totalling 989 transactions. Moshe Arkin's most active month to dispose stocks was the month of September. 2026 saw Moshe Arkin paying a total of $12,941,175.50 for 4,705,882 shares, this is the most they've acquired in one year. In 2011 Moshe Arkin cashed out on 2,581,380 shares for a total of $156,827,052.74, their largest year based on trade value.